Company overview

The patented technology underlying Cypex's products was developed at the University of Dundee during a five year project in partnership with 15 pharmaceutical companies. It enables the expression of human drug metabolising enzymes in bacteria without the need for large modifications to be made to the proteins.

Since the release of our first recombinant cytochrome P450 (CYP) on 1st February 2000, we have rapidly expanded our portfolio to over 100 products covering human drug-metabolising enzymes (including 19 CYPs and 8 SULTs), murine and canine CYPs, 33 fine chemicals, and a range of antibodies. We have also obtained the prestigious ISO9001 quality accreditation.

Drawing on our expertise in expressing recombinant cytochrome P450s and in drug metabolism, we also offer contract services both for custom protein expression and the production of drug metabolites.

To complement our high quality products we have maintained close links with the University of Dundee and the industrial members of the consortium involved in the original project. This enables Cypex to remain at the forefront of in vitro drug metabolism technology.

Mailing address:
Cypex Ltd
6 Tom McDonald Avenue
Dundee
DD2 1NH
UK

Tel.: (+44) (0)1382 562391
Fax: (+44) (0)1382 562394
Email: info@cypex.co.uk

Cypex Ltd is a company registered in Scotland with company number 190620.

Registered Office: 30 & 34 Reform St, Dundee, DD1 1RJ, UK.

VAT Registration No.: GB 734995192

Directions for visitors